Study Information
| Title: | A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer  |
| Status: | Recruiting participants |
| Conditions: | Breast Cancer,; Advanced Solid Tumors,; Cowden Syndrome |
| Interventions: | Drug: BEZ235 |
| Institutions: | Dana-Farber Cancer Institute, Massachusetts General Hospital |
| Health Topics: | Breast Cancer |
Contact Information
Dana Faber Cancer Institute/ Massachusetts General Hospital
Boston, MA 02115